A Study to Investigate the Effect of a New Postural Bio-feedback Device on Low Back Pain

NCT01572779 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2015-03-25

No results posted yet for this study

Summary

A postural bio-feedback device worn by subjects for 4-10 hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group. The device records movement and muscle activity data relating to the lower back. Bio-feedback is delivered to the subject as an audible tone, visual cue or vibration and aims to prompt the subject to alter their posture or position in line with recommendations given by the treating practitioner. Four small sensors are adhered to the lower back and send data wirelessly to a data logger carried in the pocket by the subject (the size of a small mobile phone).

Conditions

  • Low Back Pain

Interventions

DEVICE

BSM device with bio-feedback

A postural bio-feedback device worn by subjects for 4-10hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group. The device records movement and muscle activity data relating to the lower back. Bio-feedback is delivered to the subject as an audible tone, visual cue or vibration and aims to prompt the subject to alter their posture or position in line with recommendations given by the treating practitioner. Four small sensors are adhered to the lower back and send data wirelessly to a data logger carried in the pocket by the subject (the size of a small mobile phone).

DEVICE

BSM device with no bio-feedback

The BSM device is worn as a placebo with no bio-feedback given to the subject. The subjects in the control group wear the device for 4-10 hours a day for 6 days spread across 6 weeks for the sub acute low back pain group and for 8 days spread across 10 weeks for the chronic group.

Sponsors & Collaborators

  • Department of Business and Innovation, Victoria, Australia

    collaborator UNKNOWN
  • Pro-Active Medical Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Steven Jensen, MB BS FAFMM · Stanlake Specialist Centre

  • Adrian Jury, MD · Myers Street Family Medical

  • Joe Garra, MD · The Clinic Werribee

  • Peter Braun, MD · Stanlake Specialist Centre

  • Robert Laird · Austin Hospital Pysiotherapy Outpatients

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572779 on ClinicalTrials.gov